Microbiota suspension

DRUG2 trials

Sponsors

Ferring Pharmaceuticals, University Hospital, Rouen

Conditions

Crohn's DiseasesUlcerative Colitis

Phase 1

A Phase 1b Proof-of-concept Trial Exploring the Effects of FE 999322 and FE 999324 in Adults With Mild to Moderate Ulcerative Colitis

WithdrawnNCT06260267

Ferring PharmaceuticalsUlcerative Colitis

Start: 2024-03-12End: 2026-01-15Updated: 2024-10-18

Unknown Phase

Effect of Intestinal Carriage of *Pilosibacter Rotomagensis* on Intestinal Inflammatory Activity

Not yet recruitingNCT07871383

University Hospital, RouenCrohn's Diseases

Start: 2026-10-01End: 2028-10-30Target: 116Updated: 2026-10-13